Skip to Content

7,614 Results Found

  • Review
  • Open Access
5 Citations
10,915 Views
12 Pages

30 June 2022

The Peroxisome proliferator-activated receptors (PPARs) play vital roles in regulating cellular differentiation, proliferation, and caspase-mediated cell death pathways. They are regarded as promising targets for anti-tumor drug development, particul...

  • Article
  • Open Access
61 Views
19 Pages

9 November 2026

TP53 mutations create two functionally opposite states—loss of the protein or retention of a full-length mutant protein—yet are usually reported as one entity. How the two states are distributed between solid tumors and hematologic malign...

(This article belongs to the Special Issue Molecular Biomarkers and Precision Medicine in Cancer)
  • Review
  • Open Access
8 Citations
6,453 Views
24 Pages

22 December 2022

Numerous recent advancements in T-cell based immunotherapies have revolutionized the treatment of hematologic malignancies. In the race towards the first approved allogeneic cellular therapy product, there is growing interest in utilizing natural kil...

(This article belongs to the Special Issue Advance in Hematopoietic Stem Cell Transplantation)
  • Review
  • Open Access
29 Citations
3,073 Views
8 Pages

Immunotherapy in Hematologic Malignancies

  • R.R. Kansara and
  • C. Speziali

1 April 2020

The management of hematologic malignancies has traditionally relied on chemotherapy regimens, many of which are still in use today. However, with advancements in the knowledge of tumour pathophysiology, therapies are continually evolving. Monoclonal...

  • Feature Paper
  • Article
  • Open Access
10 Citations
2,068 Views
16 Pages

Assessment of Common Hematologic Parameters and Novel Hematologic Ratios for Predicting Piroplasmosis Infection in Horses

  • Juan Duaso,
  • Alejandro Perez-Ecija,
  • Esther Martínez,
  • Ana Navarro and ,
  • Adelaida De Las Heras and
  • Francisco J. Mendoza
  • + 1 author+ 0 author

20 May 2025

Equine piroplasmosis (EP) is a tick-borne disease affecting equids worldwide. Diagnosis is based on direct methods (blood smear or PCR) or indirect methods (serology); however, these techniques yield positive and negative results. Thus, an alternativ...

(This article belongs to the Special Issue Advances in Internal Medicine in Equids)
  • Review
  • Open Access
184 Views
18 Pages

Hereditary Hematologic Malignancies and Where to Find Them

  • Dinnar Yahya,
  • Milena Stoyanova,
  • Mari Hachmeriyan and
  • Mariya Levkova

26 October 2026

Although hematologic malignancies are mainly sporadic, an increasing number of cases result from an inherited predisposition. The current landscape of hematologic diagnostics includes next-generation sequencing and the integration of myeloid neoplasm...

  • Article
  • Open Access
2,185 Views
9 Pages

Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice

  • Chenyu Lin,
  • Katherine I. Zhou,
  • Michelle F. Green,
  • Bennett A. Caughey and ,
  • John H. Strickler,
  • Michael B. Datto and
  • Matthew S. McKinney
  • + 2 authors+ 0 author

30 September 2024

Background: Comprehensive genomic profiling (CGP) is frequently adopted to direct the clinical care of myeloid neoplasms and solid tumors, but its utility in the care of lymphoid and histiocytic cancers is less well defined. Methods: In this study, w...

  • Review
  • Open Access
15 Citations
6,240 Views
27 Pages

The Research Advances of Aptamers in Hematologic Malignancies

  • Yongkang Liao,
  • Shijun Xiong,
  • Zaid Ur Rehman,
  • Xiaoli He and ,
  • Hongling Peng,
  • Jing Liu and
  • Shuming Sun
  • + 2 authors+ 0 author

1 January 2023

Currently, research for hematological malignancies is very intensive, with many breakthroughs. Among them, aptamer-based targeted therapies could be counted. Aptamer is a targeting tool with many unique advantages (easy synthesis, low toxicity, easy...

(This article belongs to the Special Issue Aptamers and Cancer)
  • Review
  • Open Access
18 Citations
24,740 Views
24 Pages

Hyponatremia in Patients with Hematologic Diseases

  • Epameinondas Koumpis,
  • Matilda Florentin,
  • Eleftheria Hatzimichael and
  • George Liamis

19 November 2020

Hyponatremia is the most common electrolyte disorder in clinical practice and is associated with increased morbidity and mortality. It is frequently encountered in hematologic patients with either benign or malignant diseases. Several underlying mech...

(This article belongs to the Section Endocrinology & Metabolism)
  • Review
  • Open Access
8 Citations
5,172 Views
16 Pages

COVID-19 in Patients with Hematologic Diseases

  • Ilaria Carola Casetti,
  • Oscar Borsani and
  • Elisa Rumi

29 November 2022

The COVID-19 outbreak had a strong impact on people’s lives all over the world. Patients with hematologic diseases have been heavily affected by the pandemic, because their immune system may be compromised due to anti-cancer or immunosuppressiv...

(This article belongs to the Special Issue Biomedicines: 10th Anniversary)
  • Systematic Review
  • Open Access
1,051 Views
19 Pages

A Comprehensive Meta-Analysis of the Cardiovascular Adverse Effects of Bispecific Antibody Therapy in Hematologic Malignancies

  • Derek Tai,
  • Navneet Sandhu,
  • Aren Dermarderosian,
  • Norayr Mkrtchyan and ,
  • Daniel Park,
  • Vinisha Garg,
  • Angel Nguyen and
  • Mojtaba Akhtari
  • + 3 authors+ 0 author

Introduction: Bispecific antibodies (BsAbs) are a promising and potent therapeutic intervention for relapsed or refractory (R/R) hematologic malignancies, including acute lymphoblastic leukemia (ALL), multiple myeloma (MM), and B-cell lymphomas. Thes...

  • Review
  • Open Access
4 Citations
3,747 Views
8 Pages

COVID-19 is a systemic infection that leads to multisystem affection, including hematological changes. On the other hand, the patients who have certain hematological diseases are more susceptible to COVID-19 infection. The aim of this review is to ex...

  • Article
  • Open Access
1 Citations
2,473 Views
14 Pages

Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study

  • Jihun Kang,
  • Sang-Man Jin,
  • Seok Jin Kim,
  • Dahye Kim and ,
  • Kyungdo Han,
  • Su-Min Jeong,
  • JiWon Chang,
  • Sang Youl Rhee,
  • Taewoong Choi and
  • Dong Wook Shin
  • + 5 authors+ 0 author

23 September 2021

There have been conflicting results regarding the association between diabetes and the risk of hematologic malignancies, and its interaction with obesity is unknown. This study determined the risk of hematologic malignancies according to the glycemic...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
19 Citations
5,341 Views
17 Pages

mTOR Regulation of Metabolism in Hematologic Malignancies

  • Simone Mirabilii,
  • Maria Rosaria Ricciardi and
  • Agostino Tafuri

11 February 2020

Neoplastic cells rewire their metabolism, acquiring a selective advantage over normal cells and a protection from therapeutic agents. The mammalian Target of Rapamycin (mTOR) is a serine/threonine kinase involved in a variety of cellular activities,...

(This article belongs to the Special Issue mTOR Signaling in Metabolism and Cancer)
  • Review
  • Open Access
29 Citations
9,406 Views
15 Pages

S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy

  • Farnaz Razmkhah,
  • Sena Kim,
  • Sora Lim,
  • Abdul-Jalil Dania and
  • Jaebok Choi

29 August 2023

S100A8 and S100A9 are multifunctional proteins that can initiate various signaling pathways and modulate cell function both inside and outside immune cells, depending on their receptors, mediators, and molecular environment. They have been reported a...

(This article belongs to the Special Issue Molecular Mechanism of Leukemia)
  • Article
  • Open Access
3 Citations
2,223 Views
11 Pages

19 October 2023

Appendicitis is a prevalent surgical emergency. Although appendectomy has traditionally been the go-to treatment, recent studies suggest antibiotics can be equally effective for uncomplicated cases. However, evidence is scant regarding patients with...

(This article belongs to the Section Cancer Survivorship and Quality of Life)
  • Review
  • Open Access
9 Citations
3,178 Views
26 Pages

Malignant hematologic diseases, also referred to as hematologic tumors, encompass a series of malignant proliferative disorders of the lymphopoietic system, including leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms. The dysregu...

(This article belongs to the Topic Advances in Molecular Pathogenesis and Targeted Therapies for Multiple Myeloma)
  • Article
  • Open Access
2 Citations
5,474 Views
7 Pages

Hematologic Complications in Patients Hospitalized with COVID-19 Infection

  • Elisa Lin,
  • Ellen Araj,
  • John Markantonis,
  • Hung Luu and
  • Mingyi Chen

Introduction: This review summarizes data from patients with COVID-19 requiring intensive care unit (ICU) admission. The goals of this study are to showcase some morphological anomalies found in peripheral blood smears from COVID-19 patients and to b...

  • Review
  • Open Access
8 Citations
9,645 Views
17 Pages

What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature

  • Mihail Cotorogea-Simion,
  • Bogdan Pavel,
  • Sebastian Isac,
  • Teodora Telecan and ,
  • Irina-Mihaela Matache,
  • Anca Bobirca,
  • Florin-Teodor Bobirca,
  • Razvan Rababoc and
  • Gabriela Droc
  • + 4 authors+ 0 author

3 September 2022

Background and Objectives: Acute hematologic malignancies are a group of heterogeneous blood diseases with a high mortality rate, mostly due to acute respiratory failure (ARF). Acute respiratory distress syndrome (ARDS) is one form of ARF which repre...

(This article belongs to the Special Issue Advances in Cancer Therapy from Research to Clinical Practice—Surgical, Molecular or Systemic Management of Cancer)
  • Review
  • Open Access
23 Citations
9,377 Views
40 Pages

Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential

  • Jan Jakub Lica,
  • Bhaskar Pradhan,
  • Kawthar Safi,
  • Joanna Jakóbkiewicz-Banecka and
  • Andrzej Hellmann

9 September 2024

In this review we explore innovative approaches in the treatment of hematologic cancers by combining various therapeutic modalities. We discuss the synergistic potential of combining inhibitors targeting different cellular pathways with immunotherapi...

(This article belongs to the Section Medicinal Chemistry)
  • Review
  • Open Access
17 Citations
8,486 Views
20 Pages

The Bloody Crossroads: Interactions between Periodontitis and Hematologic Diseases

  • Michał Łobacz,
  • Paulina Mertowska,
  • Sebastian Mertowski,
  • Aleksandra Kozińska and ,
  • Wojciech Kwaśniewski,
  • Marek Kos,
  • Ewelina Grywalska and
  • Mansur Rahnama-Hezavah
  • + 3 authors+ 0 author

Periodontitis is a common oral condition that can have a significant impact on the overall health of the body. In recent years, attention has been paid to potential relationships between periodontitis and various hematological disorders. This publica...

(This article belongs to the Special Issue Dental Health and Disease: From the Molecular and Pathological Perspectives)
  • Article
  • Open Access
14 Citations
5,108 Views
16 Pages

Hematologic and Serum Biochemical Characteristics of Belgian Blue Cattle

  • Hugues Guyot,
  • Damien Legroux,
  • Justine Eppe,
  • Fabrice Bureau and ,
  • Leah Cannon and
  • Eve Ramery
  • + 1 author+ 0 author

Belgian blue (BB) cattle have an 11-bp deletion in myostatin that causes skeletal muscle hyperplasia and increased muscle mass, leading to a ‘double-muscled’ phenotype. Preliminary data suggest that this phenotype may be associated with b...

(This article belongs to the Section Veterinary Biomedical Sciences)
  • Review
  • Open Access
34 Citations
10,760 Views
23 Pages

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches

  • Ji-Yoon Noh,
  • Huiyun Seo,
  • Jungwoon Lee and
  • Haiyoung Jung

27 October 2020

Immunotherapy is extensively investigated for almost all types of hematologic tumors, from preleukemic to relapse/refractory malignancies. Due to the emergence of technologies for target cell characterization, antibody design and manufacturing, as we...

(This article belongs to the Special Issue Novel Approaches to Hematologic Malignancies by Immunotherapy)
  • Article
  • Open Access
11 Citations
6,355 Views
12 Pages

Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer

  • Signe B. Clemmensen,
  • Jennifer R. Harris,
  • Jonas Mengel-From,
  • Wagner H. Bonat and ,
  • Henrik Frederiksen,
  • Jaakko Kaprio and
  • Jacob v. B. Hjelmborg
  • + 2 authors+ 0 author

16 June 2021

We aimed to explore the genetic and environmental contributions to variation in the risk of hematologic malignancies and characterize familial dependence within and across hematologic malignancies. The study base included 316,397 individual twins fro...

(This article belongs to the Special Issue Familial Cancer and Germline Genetics)
  • Review
  • Open Access
18 Citations
5,743 Views
21 Pages

Role of Notch Receptors in Hematologic Malignancies

  • Laura Gragnani,
  • Serena Lorini,
  • Silvia Marri and
  • Anna Linda Zignego

24 December 2020

Notch receptors are single-pass transmembrane proteins that play a critical role in cell fate decisions and have been implicated in the regulation of many developmental processes. The human Notch family comprises of four receptors (Notch 1 to 4) and...

(This article belongs to the Special Issue The Roles of Notch Signaling in Cancers)
  • Article
  • Open Access
6 Citations
3,080 Views
10 Pages

Association between Periodontitis and Hematologic Cancer: An NHIRD Cohort Study in Taiwan

  • Liang-Gie Huang,
  • Cheng-Chia Yu,
  • Ming-Ching Lin,
  • Yu-Hsun Wang and
  • Yu-Chao Chang

25 April 2024

Background: Chronic periodontitis, an inflammation-related disorder affecting global populations, has been revealed to be linked to diverse cancers. Numerous epidemiological studies have not shown a link between chronic periodontitis and blood cancer...

(This article belongs to the Special Issue Oral Potentially Malignant Disorders and Oral Cavity Cancer)
  • Article
  • Open Access
7 Citations
5,087 Views
10 Pages

16 October 2025

Background/Objectives: Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease frequently complicated by hematologic abnormalities, which may reflect disease activity or treatment effects. To characterize the clinical, laborato...

(This article belongs to the Section Immunology & Rheumatology)
  • Article
  • Open Access
1,121 Views
14 Pages

Application and Modification of Nutritional Assessment Tools in Hematologic Malignancies

  • Xinying Chen,
  • Xin Zheng,
  • Chenan Liu,
  • Qibiao Shi and ,
  • Xiaoyue Liu,
  • Zhaoting Bu,
  • Hong Zhao,
  • Bing Yin,
  • Changhong Xu and
  • Hanping Shi
  • + 5 authors+ 0 author

27 February 2026

Background: Hematologic malignancies pose a critical threat to global health, with their pathological progression intrinsically linked to metabolic dysregulation and nutrient imbalance. Malnutrition accelerates the trajectory of adverse outcomes whil...

(This article belongs to the Special Issue Nursing and Supportive Care for Cancer Survivors)
  • Article
  • Open Access
4 Citations
5,099 Views
12 Pages

Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study

  • Luca Bettolini,
  • Stefano Bighetti,
  • Silvia Mariel Ferrucci,
  • Angelo Valerio Marzano and ,
  • Francesca Barei,
  • Alessandra Narcisi,
  • Matteo Bianco,
  • Andrea Carugno,
  • Nicola Zerbinati and
  • Mariateresa Rossi
  • + 26 authors+ 21 authors

3 September 2025

Background: Dupilumab, a monoclonal antibody targeting the interleukin-4 receptor α, is approved for moderate-to-severe atopic dermatitis (AD). However, its safety profile in patients with concomitant hematologic disorders remains unclear, as s...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
1,973 Views
16 Pages

Redefining Caregiver and Patient Resilience in Hematologic Malignancies: A Narrative Review

  • Valentina Zoboli,
  • Stefano Botti,
  • Daniela Manzo,
  • Federica Olivazzi and
  • Manuel Gotti

1 June 2026

Background: In hematologic malignancies, treatment allocation and outcome prediction are traditionally driven by clinical and biological parameters. However, growing evidence suggests that non-clinical factors—such as psychosocial context, care...

  • Review
  • Open Access
17 Citations
9,951 Views
9 Pages

Role of Partial Splenectomy in Hematologic Childhood Disorders

  • Giorgio Attina’,
  • Silvia Triarico,
  • Alberto Romano,
  • Palma Maurizi and ,
  • Stefano Mastrangelo and
  • Antonio Ruggiero
  • + 1 author+ 0 author

5 November 2021

The spleen is a secondary lymphoid organ that belongs to the reticular-endothelial system, directly connected to blood circulation. The spleen is greatly involved in the immune response, especially against capsulated bacteria. Splenectomy plays a fun...

(This article belongs to the Collection Biomarkers and Pathogenesis of Infectious and Autoimmune Diseases)
  • Review
  • Open Access
44 Citations
9,003 Views
22 Pages

Epigenetic Effects of Benzene in Hematologic Neoplasms: The Altered Gene Expression

  • Giovanna Spatari,
  • Alessandro Allegra,
  • Mariella Carrieri,
  • Giovanni Pioggia and
  • Sebastiano Gangemi

14 May 2021

Benzene carcinogenic ability has been reported, and chronic exposure to benzene can be one of the risk elements for solid cancers and hematological neoplasms. Benzene is acknowledged as a myelotoxin, and it is able to augment the risk for the onset o...

(This article belongs to the Collection Occupational and Environmental Carcinogenesis)
  • Article
  • Open Access
33 Citations
5,598 Views
11 Pages

Assessment of Hematologic and Biochemical Parameters for Healthy Commercial Pigs in China

  • Shuo Zhang,
  • Bo Yu,
  • Qing Liu,
  • Yongjin Zhang and ,
  • Mengjin Zhu,
  • Liangyu Shi and
  • Hongbo Chen
  • + 2 authors+ 0 author

18 September 2022

Hematologic and biochemical data are useful for indicating disease diagnosis and growth performance in swine. However, the assessment of these parameters in healthy commercial pigs is rare in China. Thus, blood samples were collected from 107 nursery...

(This article belongs to the Section Pigs)
  • Review
  • Open Access
1,411 Views
22 Pages

Cutaneous Hematologic Neoplasms in Children: Overview and Update

  • Philippe Drabent,
  • Anne Welfringer,
  • Alejandro A. Gru,
  • Thierry J. Molina and
  • Sylvie Fraitag

Cutaneous hematologic neoplasms in children are relatively rare and encompass a wide range of lymphoproliferative and myeloproliferative disorders. This review explores and updates the classification, clinical presentation, diagnostic challenges, his...

(This article belongs to the Special Issue New Insights in Paediatric Dermatopathology 2025)
  • Review
  • Open Access
2 Citations
4,467 Views
14 Pages

30 May 2021

Hematologic malignancies cause more than half a million deaths every year worldwide. Analgesics were suggested as chemopreventive agents for several cancers but so far, results from individual studies about the relationship between paracetamol (aceta...

(This article belongs to the Section Hematology)
  • Review
  • Open Access
16 Citations
7,685 Views
21 Pages

Precision Medicine in Hematologic Malignancies: Evolving Concepts and Clinical Applications

  • Rita Khoury,
  • Chris Raffoul,
  • Christina Khater and
  • Colette Hanna

Precision medicine is transforming hematologic cancer care by tailoring treatments to individual patient profiles and moving beyond the traditional “one-size-fits-all” model. This review outlines foundational technologies, disease-specifi...

(This article belongs to the Special Issue Pathogenesis, Diagnosis and Treatment of Hematologic Malignancies)
  • Article
  • Open Access
1 Citations
3,796 Views
8 Pages

Patient General Condition at Diagnosis: A Systematic Evaluation for Adults Diagnosed with Hematologic Malignancies

  • Fernando Ramos,
  • Paola González-Carmona,
  • María Isabel Porras-Guerra,
  • Sonia Jiménez-Mola and ,
  • Ana María Martínez-Peláez,
  • Agustín Blanco-Cabielles,
  • Saray Conde,
  • Abdolah Ahmadi,
  • Marta Castellanos and
  • José Antonio Rodríguez-García
  • + 18 authors+ 13 authors

27 August 2020

Several societies have published recommendations for evaluating older adults with cancer in standard conditions. It is vital to assure a proper systematic patient condition evaluation, not only in the oldest (geriatric assessment) but in all adult pa...

  • Review
  • Open Access
659 Views
37 Pages

15 September 2026

Despite significant advances in treatment for several hematologic malignancies, treatment resistance and relapse remain major challenges. Immune escape is recognized as a key mechanism that can lead to tumor evasion and treatment resistance in blood...

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
11 Citations
3,148 Views
11 Pages

Differential Impact of a Multicomponent Goals-of-Care Program in Patients with Hematologic and Solid Malignancies

  • David Hui,
  • Sairah Ahmed,
  • Nico Nortje,
  • Marina George and ,
  • Clark R. Andersen,
  • Kaycee Wilson,
  • Diana Urbauer,
  • Christopher Flowers and
  • Eduardo Bruera
  • + 4 authors+ 0 author

28 February 2023

We recently reported that an interdisciplinary multicomponent goals-of-care (myGOC) program was associated with an improvement in goals-of-care (GOC) documentation and hospital outcomes; however, it is unclear if the benefit was uniform between patie...

(This article belongs to the Special Issue Supportive Care for Patients with Cancer)
  • Review
  • Open Access
1 Citations
1,538 Views
11 Pages

A Brief Review on the Role of the Transcription Factor PBX1 in Hematologic Malignancies

  • Sofia Chatzileontiadou,
  • Kassiani Boulogeorgou,
  • Christina Frouzaki,
  • Maria Papaioannou and ,
  • Triantafyllia Koletsa and
  • Evdoxia Hatjiharissi
  • + 1 author+ 0 author

30 October 2025

Pre-B-cell leukemia factor 1 (PBX1) is a transcription factor that plays a significant role in various physiological, developmental, and oncogenic processes in humans. The mechanisms and interactions of PBX1 in both solid and hematologic malignancies...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
55 Citations
12,089 Views
28 Pages

Artificial Intelligence-Assisted Diagnostic Cytology and Genomic Testing for Hematologic Disorders

  • Lealem Gedefaw,
  • Chia-Fei Liu,
  • Rosalina Ka Ling Ip,
  • Hing-Fung Tse and ,
  • Martin Ho Yin Yeung,
  • Shea Ping Yip and
  • Chien-Ling Huang
  • + 2 authors+ 0 author

30 June 2023

Artificial intelligence (AI) is a rapidly evolving field of computer science that involves the development of computational programs that can mimic human intelligence. In particular, machine learning and deep learning models have enabled the identifi...

(This article belongs to the Section Cell Methods)
  • Case Report
  • Open Access
4 Citations
1 Views
2 Pages

Two Cases of Paralitic Ileus in Onco-Hematologic Patients

  • Francesca Carraro,
  • Elisa Rivetti,
  • Erica Romano and
  • Franca Fagioli

17 January 2012

ileus is a severe complication resulting from a variety of disorders. It occurs most commonly in patients with serious underlying medical or surgical conditions. Prompt diagnosis and appropriate management may improve the outcome. We describe 2 cases...

  • Review
  • Open Access
1,610 Views
21 Pages

Ocular Manifestations Associated with Hematologic Malignancies: Mechanisms, Diagnosis, and Management

  • Yehan Xiao,
  • Yaru Zou,
  • Mingming Yang,
  • Jing Zhang and ,
  • Kyoko Ohno-Matsui and
  • Koju Kamoi
  • + 1 author+ 0 author

30 April 2026

Background: Hematologic malignancies (HMs), including leukemia and lymphoma, are systemic diseases that may cause a wide range of ocular manifestations. Methods: We searched PubMed/MEDLINE (2015-2026) and identified articles with an emphasis on clini...

(This article belongs to the Section Cancer and Cancer-Related Research)
  • Review
  • Open Access
15 Citations
4,098 Views
9 Pages

The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review

  • Adam Suleman,
  • Abi Vijenthira,
  • Alejandro Berlin,
  • Anca Prica and
  • Danielle Rodin

7 February 2022

There is increasing interest from cancer patients and their healthcare providers in the use of virtual care in routine clinical practice. In the setting of hematologic malignancy, where patients often undergo complex and immunodepleting treatments, u...

  • Review
  • Open Access
12 Citations
4,974 Views
24 Pages

Antibody-Based Immunotherapies for the Treatment of Hematologic Malignancies

  • Justyna Jureczek,
  • Krzysztof Kałwak and
  • Piotr Dzięgiel

15 December 2024

Despite the great advancements in treatment strategies for hematological malignancies (HMs) over the years, their effective treatment remains challenging. Conventional treatment strategies are burdened with several serious drawbacks limiting their ef...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
1 Citations
2,162 Views
12 Pages

Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies

  • Chien-Tzu Huang,
  • Ching-Ping Lee,
  • Tzu-Yin Chen,
  • Yi-Chang Liu and ,
  • Shih-Feng Cho,
  • Jeng-Shiun Du,
  • Ming-Lung Yu,
  • Chung-Feng Huang,
  • Sheng-Fan Wang and
  • Hui-Hua Hsiao
  • + 5 authors+ 0 author

30 August 2023

Patients with hematologic malignancies are reported to have a more severe course of coronavirus disease 2019 (COVID-19) and be less responsive to vaccination. In this prospective study, we aimed to evaluate the serological responses to booster COVID-...

(This article belongs to the Special Issue Vaccine against COVID-19: Current State of the Art and Future Perspectives)
  • Review
  • Open Access
13 Citations
9,348 Views
27 Pages

1 July 2024

Clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing has begun to transform the treatment landscape of genetic diseases. The history of the discovery of CRISPR/CRISPR-associated (Cas) proteins/single-guide RNA (sgRNA)...

(This article belongs to the Special Issue Research Progress in Hematological Malignancies: A Molecular Genetics Perspective)
  • Review
  • Open Access
17 Citations
12,027 Views
16 Pages

28 July 2022

Hematopoietic stem cell aging, through the acquisition of somatic mutations, gives rise to clonal hematopoiesis (CH). While a high prevalence of CH has been described in otherwise healthy older adults, CH confers an increased risk of both hematologic...

(This article belongs to the Special Issue Molecular Pathways in Hematologic Neoplasm)
  • Review
  • Open Access
29 Citations
5,581 Views
24 Pages

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation

  • Aneta Sevcikova,
  • Ivana Fridrichova,
  • Nataliia Nikolaieva,
  • Lenka Kalinkova and ,
  • Radoslav Omelka,
  • Monika Martiniakova and
  • Sona Ciernikova
  • + 2 authors+ 0 author

8 May 2023

Hematologic malignancies are a group of neoplastic conditions that can develop from any stage of the hematopoiesis cascade. Small non-coding microRNAs (miRNAs) play a crucial role in the post-transcriptional regulation of gene expression. Mounting ev...

(This article belongs to the Collection miRNAs: New Insights in Tumor Biology)
  • Review
  • Open Access
3 Citations
2,819 Views
29 Pages

Sarcopenia in Older Adults with Hematologic Malignancies: A Comprehensive Review of Epidemiology, Prognosis, and Interventions

  • Samuel J. Yates,
  • Nadine H. Abdallah,
  • Konstantinos Christofyllakis,
  • Brandon N. VanderVeen and ,
  • Timothy S. Pardee,
  • Denise K. Houston,
  • Stephen B. Kritchevsky and
  • Heidi D. Klepin
  • + 3 authors+ 0 author

3 February 2026

Hematologic malignancies, including leukemias, lymphomas, and multiple myeloma, are diseases of older adults (age ≥ 60 years). Treatment decisions in older adults with cancer are heavily influenced by patient fitness: the ability of an individual...

(This article belongs to the Section Cancer Epidemiology and Prevention)

of 153